Report : Metabolomics Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service Type (Targeted Metabolomics Service and Untargeted Metabolomics Service) and Application (Pharmaceutical and Biotechnology Industry, Agritech, and Environment)
According to our new research study on “Metabolomics Services Market Forecast to 2028 – COVID-19 Impact and Analysis – by Service Type and Application,” the market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% from 2021 to 2028. The report highlights trends existing in the market, and factors governing the market growth. Targeted metabolomics is a quantitative method in which a group of metabolites is quantified by using 15N or 13C compounds that are identified as labeled isotopes. BGI, a China-based company, offers targeted metabolomics services for the detection and analysis of specific metabolites. The company's targeted metabolomics services can precisely employed to monitor the dynamic metabolic process, explore metabolic mechanisms, and verify possible metabolic biomarkers. Based on state-of-the-art LC-MS/MS systems and techniques, the metabolomics services of BGI offers validated workflows of targeted metabolomics such as vitamins, amino acids, hormones, and other small molecules.
BASF SE, TMIC, Creative Proteomics, BGI, RTI International, Afekta Technologies Ltd., Fred Hutchinson Cancer Research Center, West Coast Metabolomics Center are among the leading companies operating in the metabolomics services market. These companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolios. In July 2020, Creative Proteomics, an integrated contract research organization (CRO) that offers a comprehensive spectrum of drug development services announced the debut of its fully developed untargeted metabolomics services to assist researchers.
The global metabolomics services market, based on service type, has been segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold a larger share of the market in 2021. Moreover, the targeted metabolomics service segment is anticipated to register a higher CAGR in the market during the forecast period.
On the basis of geography, the metabolomics services market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).